In this piece, the authors use findings from the 2021 Access to Medicine Index to identify four areas where pharmaceutical companies can take urgent action to ensure equal access to COVID-19 vaccines and treatments in low- and middle-income countries (LMICs).:
File for registration rapidly, widely and on the basis of the most rigorous standards
Price products equitably
Expand production and supply capacity
Disclose more information about efforts and progress against these principals
Read the full article here.